Gene expression and biological significance of hexokinase in erythroid cells

Acta Haematologica

Volumn 108, Issue 4, 2002, Pages 204-209

  Murakami, Koko ^a   Kanno, Hitoshi ^b   Tancabelic, Jakica ^a   Fujii, Hisaichi ^b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glycolysis; Hemolytic anemia

Indexed keywords

HEXOKINASE; ISOENZYME; PORIN;

ADULT; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHROMOSOME 10; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ERYTHROCYTE METABOLISM; ERYTHROID CELL; EXON; FETUS; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE STRUCTURE; GENOME ANALYSIS; HEMOLYTIC ANEMIA; HUMAN; INTRON; MITOCHONDRION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; STEM CELL; TESTIS;

ANEMIA, HEMOLYTIC; ERYTHROCYTES; GENE EXPRESSION; HEXOKINASE; HUMANS; ISOENZYMES; PROMOTER REGIONS (GENETICS);

EID: 0036435503     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065656     Document Type: Article

References (43)

1. Hirono A, Kanno H, Miwa S, Beutler E: Pyruvate kinase deficiency and other enzymopathies of the red cell; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, ed 8. New York, McGraw-Hill, 2001, pp 4637-4664.
2. Katzen HM, Schimke RT: Multiple forms of hexokinase in the rat: Tissue distribution, age dependency, and properties. Proc Natl Acad Sci USA 1965;54:1218-1225.
3. Wilson JE: Hexokinases. Rev Physiol Biochem Pharmacol 1995;126:65-198.
4. Printz RL, Magnuson MA, Granner DK: Mammalian glucokinase. Annu Rev Nutr 1993;13:463-496.
5. Rogers P, Fischer R, Harris H: An electrophoretic study of the distribution and properties of human hexokinases. Biochem Genet 1975;13:857-866.
6. Rijksen G, Jansen F, Kraaijenhagen RJ, Van der Vlist MJM, Vlug AMC, Staal GEJ: Separation and characterization of hexokinase I subtypes from human erythrocytes. Biochim Biophys Acta 1981;659:291-301.
7. Magnani M, Serafini G, Stocchi V: Hexokinase type I multiplicity in human erythrocytes. Biochem J 1988;254:617-620.
8. Murakami K, Piomelli S: Identification of the cDNA for human red blood cell-specific hexokinase isozyme. Blood 1997;89:762-766.
9. Ruzzo A, Andreoni F, Magnani M: Structure of the human hexokinase type I gene and nucleotide sequence of the 5(flanking region). Biochem J 1998;331:607-617.
10. Murakami K, Kanno H, Miwa S, Piomelli S: Human HK-R isozyme: Organization of the hexokinase I gene, the erythroid-specific promoter, and transcription initiation site. Mol Genet Metab 1999;67:118-130.
11. Corash LM, Piomelli S, Chen MC, Seaman C, Gross E: Separation of erythrocytes according to age on a simplified density gradient. J Lab Clin Med 1974;84:147-151.
12. R). Blood)1990;75:770-775.
13. Beutler E: The relationship of red cell enzymes to red cell life-span. Blood Cells 1988;14:69-91.
14. Valentine WN, Oski FA, Paglia DE, Baughan MA, Schneider AS, Naiman JL: Hereditary hemolytic anemia with hexokinase deficiency: Role of hexokinase in erythrocyte aging. N Engl J Med 1967;276:1-11.
15. Magnani M, Stocchi V, Dacha M, Fornaini G: Rabbit red blood cell hexokinase. Mol Cell Biochem 1984;61:83-92.
16. Nijhof W, Wierega PK, Staal GEJ, Jansen G: Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro. Blood 1984;64:607-613.
17. Kanno H, Fujii H, Miwa S: Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem Biophys Res Commun 1992; 188:516-523.
18. Noguchi T, Yamada K, Inoue H, Matsuda T, Tanaka T: The L- and R-type Isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem 1987;262:14366-14371.
19. Max-Audit I, Eleouet J-F, Romeo P-H: Transcriptional regulation of the pyruvate kinase erythroid-specific promoter. J Biol Chem 1993; 268:5431-5437.
20. Mori C, Nakamura N, Welch JE, Shiota K, Eddy E: Testis-specific expression of mRNA for a unique human type 1 hexokinase lacking the porin-binding domain. Mol Reprod Dev 1996;44:14-22.
21. Mori C, Nakamura N, Welch JE, Gotoh H, Goulding EH, Fujioka M, Eddy EM: Mouse spermatogenic cell-specific type 1 hexokinase (mHk1-s) transcripts are expressed by alternative splicing from the mHk1 gene and the HK1-S protein is localized mainly in the sperm tail. Mol Reprod Dev. 1998;49:374-385.
22. Andreoni F, Ruzzo A, Magnani M: Structure of the 5)region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA. Biochem Biophys Acta 2000;1493:19-26.
23. Peters LL, Lane PW, Andersen SG, Gwynn B, Barker JE, Beutler E: Downeast anemia (dea), a new mouse model of severe nonspherocytic hemolytic anemia caused by hexokinase (HK-I) Deficiency. Blood Cells Mol Dis 2001;27:850-860.
24. Kanno H, Murakami K, Hariyama Y, Ishikawa K, Miwa S, Fujii H: Homozygous intragenic deletion of type-I hexokinase gene causes lethal hemolytic anemia of the affected fetus. Blood 2002;100:1930.
25. Goebel KM, Gassel WD, Goebel FD, Kaffarnik H: Hemolytic anemia and hexokinase deficiency associated with malformations. Klin Wochenschr 1972;50:849.
26. Gilsanz F, Meyer E, Paglia DE, Valentine WN: Congenital hemolytic anemia due to hexokinase deficiency. Am J Dis Child 1978;132: 636.
27. Magnani M, Stocchi V, Canestrari F, Dach̀ M, Balestri P, Farnetani MA, Giorgi D, Fois A, Fornaini G: Human erythrocyte hexokinase deficiency: A new variant with abnormal kinetic properties. Br J Haematol 1985;61:41.
28. Paglia DE, Shende A, Lanzkowsky P, Valentine WN: Hexokinase 'New Hyde Park': A low activity erythrocyte isozyme in a Chinese kindred. Am J Hematol 1981;10:107-117.
29. Coerver KA, Gray SM, Barnes JE, Armstrong DL, McCabe ERB: Developmental expression of hexokinase 1 and 3 in rats. Histochem Cell Biol 1998;109:75-86.
30. Kanno H: Hexokinase: Gene structure and mutations. Baillières Best Pract Res Clin Haematol 2000;13:83-88.
31. Benito A, Silva M, Grillot D, Nunez G, Fernandez-Luna JL: Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood 1996;87: 3837-3843.
32. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ, Gregory T: GATA-1 and erythro-poietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 1999;94:87-96.
33. Desagher S, Martinou J: Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000;10:369-377.
34. Kennedy SG, Kandel ES, Cross TK, Hay N: Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 1999;19:5800-5810.
35. Vander Heiden MG, Chandel NS, Schumacker PT, Thompson CB: Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell 1999;3:159-167.
36. Plas DR, Talapatra S, Edinger AL, Rathmell JC, Thompson CB: Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J Biol Chem 2001;276:12041-12048.
37. Parry DM, Pedersen PL: Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem 1983;258:10904-10912.
38. Nakashima RA, Mangan PS, Colombini M, Pedersen PL: Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N) dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry 1986;25:1015-1021.
39. Nakashima RA: Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites. J Bioenerg Biomembr 1989;21:461-470.
40. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N: Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001;15:1406-1418.
41. Chen WS, Xu P-Z, Gottlob K, Chen M-L, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, Kadowaki T, Hay N: Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev 2001;15:2203-2208.
42. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB: Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 2002;277:11392-11400.
43. Aisaki K, Kanno H, Oyaizu N, Hara Y, Miwa S, Ikawa Y: Apoptotic changes precede mitochondrial dysfunction in red cell-type pyruvate kinase mutant mouse erythroleukemia cell lines. Jpn J Cancer Res 1999;90:171-179.